Key Takeaways QBTS reports a Q4 loss of 12 cents, missing estimates, as revenues rise 19% y/y.D-Wave posts $13.4M in Q4 bookings, down 27%, but January bookings exceed $30M.QBTS ends 2025 with $884.5M cash after warrant exercises and the Advantage2 system launch.D-Wave Quantum Inc. (QBTS) reported a fourth-quarter 2025 net loss of 12 cents per share compared with the Zacks Consensus Estimate of a loss of 5 cents. However, the figure compares favorably with the year-ago period’s loss of 37 cents.Excluding on ...

Group 1 - Clarivate shares have rebounded significantly, recovering from a 33% loss earlier in February, with a 29.9% increase noted recently [1][2] - The company reported strong fourth-quarter 2025 financial results, with revenue of $617 million, surpassing analysts' expectations of $604.8 million, and adjusted EPS of $0.20, exceeding the anticipated $0.16 [2][3] - Clarivate's free cash flow for Q4 2025 was $89.2 million, marking a 50.9% year-over-year increase, despite a 6.9% decline in sales [3] Group 2 - For 2026, management projects adjusted diluted EPS between $0.70 and $0.80, indicating an expected 8.7% year-over-year increase, and anticipates free cash flow growth to between $365 million and $435 million, representing a 9.5% year-over-year growth based on 2025 figures [4] - Despite the recent rise in stock price, Clarivate shares are still trading at a discount, at 2.6 times operating cash flow compared to a five-year average of 7.6 [5]

Management characterizes 2025 as a positive inflection point, marking the first time since 2019 that the company delivered on its initial full-year financial guidance. The decision to sell the Life Sciences & Health (LS&H) business is intended to sharpen focus on the Academia & Government (A&G) and Intellectual Property (IP) segments while aggressively deleveraging the balance sheet. Performance attribution for the year includes a 90 basis point improvement in organic ACV growth, driven by enhanced sa ...

Management also addressed investor concerns about AI disruption. Shem Tov said Clarivate views AI as “an amplifier” rather than a threat, arguing its customers operate in high-stakes environments where provenance and accuracy are critical. He described the company’s AI approach as “Intelligence Amplified,” centered on:As part of a strategic review launched in February, Shem Tov said Clarivate has initiated a process to sell its Life Sciences & Healthcare (LS&H) business. He said a sale could increase focus ...

Clarivate (NYSE: CLVT) stock is surging higher in Tuesday's trading. The company's share price was up 31.4% as of 1 p.m. ET. Meanwhile, the S&P 500 was up 0.7%, and the Nasdaq Composite was up 1%. In addition to bullish momentum for the broader market lifting tech valuations, the stock is getting a big boost from the company's recent earnings report. The analytics specialist published its fourth-quarter results after the market closed yesterday, posting sales and earnings beats and issuing better-than-expe ...

U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Tuesday.Henry Schein reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.30 per share. The company reported quarterly sales of $3.437 billion which beat the analyst consensus estimate of $3.345 billion.Henry Schein shares jumped 8.3% to $87.24 on Tuesday.Here are some other big stocks recording gains in today’s session.Photo via Shutterstock ...

Clarivate plc (CLVT) announced Tuesday net income for the fourth quarter of $3.1 million or $0.00 per share, compared to a net loss of $191.8 million or $0.27 per share, in the prior-year quarter.Excluding items, adjusted net income for the quarter was $0.20 per share, compared to $0.21 per share in the year-ago quarter.Total revenues for the quarter declined to $617.0 million from $663.0 million in the same quarter last year. Revenues were down 1.2 percent on an organic basis.Looking ahead to fiscal 2026, ...

Core Viewpoint - Clarivate Plc is actively restructuring its financial and product strategies, focusing on debt reduction and enhancing its subscription-based offerings amid mixed market sentiment. Group 1: Financial Actions - The company has fully redeemed $100 million of its 4.50% senior secured notes due 2026, completing the transaction on January 30 using cash on hand [1] - Clarivate repurchased approximately 21 million shares for $75 million in Q4 2025 and about 56 million shares for $225 million for the full year, reflecting its commitment to simplifying its capital structure and improving financial flexibility [2] - The total debt balance managed by the company is roughly $4.49 billion [1] Group 2: Product Development - Clarivate introduced Clarivate Nexus, an AI-powered academic assistant aimed at helping students and researchers access trusted library content and discovery tools [2] - The company is focusing on transitioning from transactional sales to subscription offerings as part of its Value Creation Plan [3] - Efforts are being made to upgrade sales talent and enhance product innovation [3] Group 3: Market Sentiment - Goldman Sachs downgraded Clarivate's stock to Neutral from Buy, reducing the price target from $4.20 to $3.60 due to concerns regarding the company's Value Creation Plan [3] - There are expectations that it may take time for the company's strategic changes to positively impact organic revenue growth [3] Group 4: Company Overview - Clarivate Plc is a leading global provider of transformative intelligence, offering subscription-based data, analytics, and software to various sectors including academic, government, legal, and life sciences [4]

Core Insights - Clarivate Plc (NYSE:CLVT) is actively pursuing AI initiatives, notably with the launch of Clarivate Nexus, an AI-powered academic assistant aimed at enhancing library content and services for students and researchers [1][2] Company Developments - Clarivate Nexus will initially be available as a browser extension, with plans for future integration into campus systems, including learning management systems and library portals, set for early access in Q3 2026 [2] - The company has entered a multi-year agreement with Iran's Ministry of Higher Education and Scientific Research, focusing on strategic guidance, data analytics, and skills development [2] Business Segments - Clarivate operates in three main segments: academic-focused AI services, intellectual property (IP) management software, and life sciences and healthcare research and development tools [3]

Core Insights - The industrials sector has several oversold stocks that present potential buying opportunities for undervalued companies [1] Group 1: Oversold Stocks - Alight Inc (NYSE:ALIT) has an RSI value of 29.4, with a stock price that fell around 20% over the past month, closing at $1.56 [5] - Clarivate PLC (NYSE:CLVT) has an RSI value of 29, with a stock price that decreased by approximately 19% in the last month, closing at $2.81 [5] - CBIZ Inc (NYSE:CBZ) has an RSI value of 27.6, with a stock price that dropped around 16% over the past five days, closing at $44.97 [5]